Skip to main content

Table 1 Demographics and characteristics data of epilepsy patients by different anti-epileptic drugs used as monotherapy

From: Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan

  Levetiracetam Valproic acid Carbamazepine Lamotrigine Lacosamide Others
Patients* [N (%)] 3780 (32.9) 2424 (21.1) 1608 (14.0) 1288 (11.2) 1068 (9.3) 1322 (11.5)
Mean age** [y (SD**)] 55.2 (22.4) 10.4 (3.2) 21.5 (14.2) 45.1 (21.8) 13.9 (8.0) 52.4 (18.3)
Gender* (%) M/F 51.4/48.6 41.7/58.3 51.1/48.9 29.2/69.8 50.7/49.3 49.2/51.8
Patients with migraine** [N (%)] 645 (5.6) 234 (2.0) 848 (7.3) 26 (0.2) 102 (0.8) 472 (4.1)
Psychiatric disorders** [N (%)] 552 (4.8) 427 (3.7) 687 (5.9) 19 (0.1) 98 (0.8) 734 (6.3)
Other comorbidities [N (%)] 321 (2.7) 147 (1.2) 23 (0.2) 18 (0.1) 52 (0.4) 845 (7.3)
  1. Phenobarbital, phenytoin, gabapentin, pregabalin and oxcarbazepine were categorized as others AEDs
  2. Total (11,490 N) Patients
  3. SD Standard deviation
  4. *P < 0.05; **P < 0.005